Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8991)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 28, 2016 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jou E, Rajdev L. Current and emerging therapies in unresectable and recurrent gastric cancer. World J Gastroenterol 2016; 22(20): 4812-4823 [PMID: 27239108 DOI: 10.3748/wjg.v22.i20.4812] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i20/4812.htm |
| Number | Citing Articles |
| 1 |
María L Bacigalupo, Pablo Carabias, María F Troncoso. Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression. World Journal of Gastroenterology 2017; 23(29): 5266-5281 doi: 10.3748/wjg.v23.i29.5266
|
| 2 |
Zhihong Huang, Ping Wei. Compound Kushen Injection for gastric cancer. Medicine 2019; 98(45): e17927 doi: 10.1097/MD.0000000000017927
|
| 3 |
Hao Wang, Ying‑Hua Luo, Gui‑Nan Shen, Xian‑Ji Piao, Wan‑Ting Xu, Yi Zhang, Jia‑Ru Wang, Yu‑Chao Feng, Jin‑Qian Li, Yu Zhang, Tong Zhang, Shi‑Nong Wang, Hui Xue, Hong‑Xing Wang, Chang‑Yuan Wang, Cheng‑Hao Jin. Two novel 1,4‑naphthoquinone derivatives induce human gastric cancer cell apoptosis and cell cycle arrest by regulating reactive oxygen species‑mediated MAPK/Akt/STAT3 signaling pathways. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10500
|
| 4 |
Yubin Feng, Maomao Wu, Shuang Hu, Xiaoqing Peng, Feihu Chen. LncRNA DDX11-AS1: a novel oncogene in human cancer. Human Cell 2020; 33(4): 946 doi: 10.1007/s13577-020-00409-8
|
| 5 |
|
| 6 |
Jianling Xia, Hongqiang Wang, Shi Li, Qinghui Wu, Li Sun, Hongxiang Huang, Ming Zeng. Ion channels or aquaporins as novel molecular targets in gastric cancer. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0622-y
|
| 7 |
Padmaraju Vasudevaraju, Malla Rama Rao. Immunotherapy for Gastrointestinal Malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 79 doi: 10.1007/978-981-15-6487-1_6
|
| 8 |
Giulia Accordino, Sara Lettieri, Chandra Bortolotto, Silvia Benvenuti, Anna Gallotti, Elisabetta Gattoni, Francesco Agustoni, Emma Pozzi, Pietro Rinaldi, Cristiano Primiceri, Patrizia Morbini, Andrea Lancia, Giulia Maria Stella. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective. Cancers 2020; 12(8): 2105 doi: 10.3390/cancers12082105
|
| 9 |
Raquel Carvalho Montenegro, Alison Howarth, Alessandro Ceroni, Vita Fedele, Batoul Farran, Felipe Pantoja Mesquita, Martin Frejno, Benedict-Tilman Berger, Stephanie Heinzlmeir, Heba Z. Sailem, Roberta Tesch, Daniel Ebner, Stefan Knapp, Rommel Burbano, Bernhard Kuster, Susanne Müller. Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget 2020; 11(5): 535 doi: 10.18632/oncotarget.27462
|
| 10 |
Xuefeng Yang, Mingda Wang, Bohao Lin, Dongjie Yao, Jin Li, Xianchun Tang, Sanhua Li, Yun Liu, Rui Xie, Shouyang Yu. miR-487a promotes progression of gastric cancer by targeting TIA1. Biochimie 2018; 154: 119 doi: 10.1016/j.biochi.2018.08.006
|
| 11 |
Akira Okita, Hiroo Imai, Masahiro Takahashi, Hidekazu Takahashi, Sho Umegaki, Yoshifumi Kawamura, Sakura Hiraide, Kota Ouchi, Yuko Sato, Yoshinari Okada, Keigo Komine, Ken Saijo, Shin Takahashi, Masanobu Takahashi, Hidekazu Shirota, Hisatsugu Ohori, Makio Gamoh, Chikashi Ishioka. Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective Analysis. The Tohoku Journal of Experimental Medicine 2018; 245(2): 123 doi: 10.1620/tjem.245.123
|
| 12 |
Zishu Wang, Kaikai Yu, Yudong Hu, Fang Su, Zhenyuan Gao, Ting Hu, Yang Yang, Xiangliao Cao, Feng Qian. Schisantherin A induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cells. Biochemical Pharmacology 2020; 173: 113673 doi: 10.1016/j.bcp.2019.113673
|
| 13 |
Luo Li, Keshan Wang, Zhenguo Liu, Yajuan Lü, Congcong Wang, Xuefei Yi, Jianping Guo. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02609-y
|
| 14 |
Shoichiro Mukai, Naohide Oue, Takashi Oshima, Takeharu Imai, Yohei Sekino, Ririno Honma, Naoya Sakamoto, Kazuhiro Sentani, Hiroki Kuniyasu, Hiroyuki Egi, Kazuaki Tanabe, Kazuhiro Yoshida, Hideki Ohdan, Wataru Yasui. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer. The Journal of Pathology 2017; 243(1): 100 doi: 10.1002/path.4931
|
| 15 |
Markus Moehler, Min-Hee Ryu, Mikhail Dvorkin, Keun-Wook Lee, Hasan Ş Coşkun, Rachel Wong, Hyun C Chung, Artem Poltoratsky, Akihito Tsuji, Chia Jui Yen, Alina S Muntean, Samuel Le Sourd, Gina M Vaccaro, Lindsay Overton, Narikazu Boku, Zev A Wainberg, Manish Patel, Maitreyi Sharma, Huiling Xiong, Ilaria Conti, Julien Taieb, Yung-Jue Bang. Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design. Future Oncology 2019; 15(6): 567 doi: 10.2217/fon-2018-0668
|
| 16 |
Yunfei Zhang, Fengchang Huang, Ning Xu, Jin Wang, Dan Li, Liang Yin. Overexpression of serum extracellular vesicle microRNA-215-5p is associated with early tumor recurrence and poor prognosis of gastric cancer. Clinics 2021; 76: e2081 doi: 10.6061/clinics/2021/e2081
|
| 17 |
Helem Ferreira Ribeiro, Carla de Castro Sant’ Anna, Valdenira de Jesus Oliveira Kato, Rafael Maia de Sousa Brasil, Amanda Braga Bona, Danielle Feio da Costa, Isamu Komatsu Lima, Paulo Cardoso Soares, Ana Paula Araújo Guimarães, Paulo Pimentel de Assumpção, Rommel Rodriguez Burbano. CDC25B Inhibition by Menadione: A Potential New Therapeutical Approach. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(17): 2927 doi: 10.2174/1871520622666220418131935
|
| 18 |
Batoul Farran, Susanne Müller, Raquel C Montenegro. Gastric cancer management: Kinases as a target therapy. Clinical and Experimental Pharmacology and Physiology 2017; 44(6): 613 doi: 10.1111/1440-1681.12743
|
| 19 |
Jicai Wang, Zhilei Su, Shounan Lu, Wen Fu, Zhifa Liu, Xingming Jiang, Sheng Tai. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clinica Chimica Acta 2018; 485: 229 doi: 10.1016/j.cca.2018.07.004
|
| 20 |
Julien Taieb, Markus Moehler, Narikazu Boku, Jaffer A. Ajani, Eduardo Yañez Ruiz, Min-Hee Ryu, Silke Guenther, Vikram Chand, Yung-Jue Bang. Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives. Cancer Treatment Reviews 2018; 66: 104 doi: 10.1016/j.ctrv.2018.04.004
|
| 21 |
High Expression of TTYH3 is Related to Poor Clinical Outcomes in Human Gastric Cancer. Journal of Clinical Medicine 2019; 8(11): 1762 doi: 10.3390/jcm8111762
|
| 22 |
Naohide Oue, Kazuhiro Sentani, Naoya Sakamoto, Naohiro Uraoka, Wataru Yasui. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells. International Journal of Clinical Oncology 2019; 24(7): 771 doi: 10.1007/s10147-019-01443-9
|
| 23 |
Tianfang Xia, Zhenguo Pan, Jie Zhang. CircSMC3 regulates gastric cancer tumorigenesis by targeting miR‐4720‐3p/TJP1 axis. Cancer Medicine 2020; 9(12): 4299 doi: 10.1002/cam4.3057
|
| 24 |
Yifan Lian, Zeling Cai, Huangbo Gong, Songling Xue, Dongdong Wu, Keming Wang. HOTTIP: a critical oncogenic long non-coding RNA in human cancers. Molecular BioSystems 2016; 12(11): 3247 doi: 10.1039/C6MB00475J
|
| 25 |
Jiao Guo, Chun‐Dong Zhang, Jia‐Xiang An, Yun‐Yun Xiao, Shuai Shao, Nuo‐Ming Zhou, Dong‐Qiu Dai. Expression of miR‐634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cells. Cancer Medicine 2018; 7(3): 776 doi: 10.1002/cam4.1204
|
| 26 |
Didem Tunalı, Sule Yildiz Oğuz, Ugur Selek, Emre Balik, Senol Tonyali, Sertac Yazici, Özgür Öktem. Textbook of Gastrointestinal Oncology. 2019; : 633 doi: 10.1007/978-3-030-18890-0_35
|
| 27 |
Yanfeng Li, Guanyu Zhu, Yan Ma, Hongyan Qu. Retracted: lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR‐219‐1. Journal of Cellular Biochemistry 2019; 120(12): 19457 doi: 10.1002/jcb.29239
|
| 28 |
Yao Wang, Yuanyuan Guo, Tianchi Zhuang, Ting Xu, Minghui Ji. SP1-Induced Upregulation of lncRNA LINC00659 Promotes Tumour Progression in Gastric Cancer by Regulating miR-370/AQP3 Axis. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.936037
|
| 29 |
Hoda Fazaeli, Azar Sheikholeslami, Fatemeh Ghasemian, Elaheh Amini, Mohsen Sheykhhasan. The Emerging Role of LncRNA FENDRR in Multiple Cancers: A
Review. Current Molecular Medicine 2023; 23(7): 606 doi: 10.2174/1566524022666220509122505
|
| 30 |
Bihong Xu, Chunyu Huang, Xianzi Yang, Xiangzhao Li, Liang Li, Yanqing Ding. Significance and prognostic role of human epidermal growth factor receptor 2 and RAB1A expression in gastric cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.7992
|
| 31 |
Chen Xu, Yalan Liu, Dongxian Jiang, Qian Li, Xiaowen Ge, Ying Zhang, Jie Huang, Jieakesu Su, Yuan Ji, Jun Hou, Shaohua Lu, Yingyong Hou, Tianshu Liu. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type. Oncotarget 2017; 8(20): 33185 doi: 10.18632/oncotarget.16567
|
| 32 |
Xiao-ying Zhang, Pei-ying Zhang. Gastric cancer: somatic genetics as a guide to therapy. Journal of Medical Genetics 2017; 54(5): 305 doi: 10.1136/jmedgenet-2016-104171
|
| 33 |
George Gourzoulidis, Maria Koulentaki, Anna Koumarianou, Epaminondas Samadas, Nikolaos Androulakis, Spyridon Xynogalos, Pavlos Papakotoulas, Ioannis Boukovinas, Michalis Karamouzis, John Souglakos, Vasiliki Chotzagiannoglou, Alexandra Beletsi, Georgia Kourlaba. Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Greece. Expert Review of Pharmacoeconomics & Outcomes Research 2022; 22(2): 259 doi: 10.1080/14737167.2021.1921576
|
| 34 |
Lin Shen, Jun Guo, Qingyuan Zhang, Hongming Pan, Ying Yuan, Yuxian Bai, Tianshu Liu, Qing Zhou, Jun Zhao, Yongqian Shu, Xiaoming Huang, Siyang Wang, Jie Wang, Aiping Zhou, Dingwei Ye, Ting Sun, Yujuan Gao, Silu Yang, Zoubai Wang, Jian Li, Yi-Long Wu. Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study. Journal for ImmunoTherapy of Cancer 2020; 8(1): e000437 doi: 10.1136/jitc-2019-000437
|
| 35 |
Olga Sokolova, Michael Naumann. NF‐κB Signaling in Gastric Cancer. Toxins 2017; 9(4): 119 doi: 10.3390/toxins9040119
|
| 36 |
Kizuki Yuza, Masayuki Nagahashi, Satoshi Watanabe, Kazuaki Takabe, Toshifumi Wakai. Hypermutation and microsatellite instability in gastrointestinal cancers. Oncotarget 2017; 8(67): 112103 doi: 10.18632/oncotarget.22783
|